Back
Royal Caribbean Group Vs. PROCEPT BioRobotics Industry Stock Comparison
Buy
81
RCL
Royal Caribbean Group
Last Price:
210.07
Seasonality Move:
11.63%
Buy
89
PRCT
PROCEPT BioRobotics
Last Price:
96.87
Seasonality Move:
3.14%
Buy
81
Royal Caribbean Group (RCL)
is a Buy
Is Royal Caribbean Group a Buy, Sell or Hold?
- The current Royal Caribbean Group [RCL] share price is $203.52. The Score for RCL is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- RCL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
89
PROCEPT BioRobotics (PRCT)
is a Buy
Is PROCEPT BioRobotics a Buy, Sell or Hold?
- The current PROCEPT BioRobotics [PRCT] share price is $91.00. The Score for PRCT is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- PRCT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
RCL Stock Price Chart
What is Royal Caribbean Group's stock price today?
-
The Royal Caribbean Group share price today is $203.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCL is experiencing slight selling pressure.
PRCT Stock Price Chart
What is PROCEPT BioRobotics's stock price today?
-
The PROCEPT BioRobotics share price today is $91.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.26 | Buy |
| Relative Strength Index (14 RSI): | 70.54 | Buy |
| Chaikin Money Flow: | -964628 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (177.82 - 200.56) | Buy |
| Bollinger Bands (100): | (151.16 - 182.1) | Buy |
PRCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 73.94 | Buy |
| Chaikin Money Flow: | 4690720 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (68.37 - 79.17) | Buy |
| Bollinger Bands (100): | (62.3 - 77.66) | Buy |
RCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 201.7 | Buy |
| 20-day SMA: | 191.82 | Buy |
| 50-day SMA: | 176.32 | Buy |
| 200-day SMA: | 149.28 | Buy |
| 8-day EMA: | 200.73 | Buy |
| 20-day EMA: | 193.41 | Buy |
| 50-day EMA: | 180.53 | Buy |
| 200-day EMA: | 151.8 | Buy |
PRCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.03 | Buy |
| 20-day SMA: | 72.33 | Buy |
| 50-day SMA: | 76.1 | Buy |
| 200-day SMA: | 61.48 | Buy |
| 8-day EMA: | 73.79 | Buy |
| 20-day EMA: | 73.26 | Buy |
| 50-day EMA: | 73.2 | Buy |
| 200-day EMA: | 62.6 | Buy |
Royal Caribbean Group Earnings Growth & RCL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.95 per share, and an increase next year of $2.06 per share.
PROCEPT BioRobotics Earnings Growth & PRCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.33 per share.
Royal Caribbean Group Technical Analysis
| Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PROCEPT BioRobotics Technical Analysis
| Oct 15 | Oct 16 | Oct 17 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||